NY A 11627
in committeeRelates to coverage for the treatment of ameloblastoma
New York · 2025-2026 Regular Session
Quick answers
Did NY A 11627 pass?
Not yet. NY A 11627 is in committee as of 2026-07-29 and has not come to a final vote. Latest recorded action (2026-07-29): REFERRED TO INSURANCE
What is NY A 11627 about?
NY A 11627 is a bill in the 2025-2026 Regular Session titled “Relates to coverage for the treatment of ameloblastoma”.
Who sponsors NY A 11627?
Rules Committee is the primary sponsor of NY A 11627, joined by 1 cosponsor.
- Introduced
- —
- Latest action
- 2026-07-29 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Rules Committeeprimary
- Josh Jensencosponsor
Committees
Not provided by source.
Action timeline
2026-07-29
REFERRED TO INSURANCE
referral-committee
Versions
- A11627Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-07-30T13:51:23.376470Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 11627. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.